Our distinguised Clinical Advisory Board consists of members with expertise in the research and clinical development of drugs for respiratory viral infection.

Andrew Pavia, M.D.

Andrew Pavia, MD is the George and Esther Gross Presidential Professor and Chief of the Division of Pediatric Infectious Diseases at the University of Utah Health Sciences Center.  He is very active as an infectious disease investigator and in policy.  Dr. Pavia serves on several advisory committees for federal and state government on vaccine policy, biodefense, and pandemic influenza preparedness.  He leads several committees of the Infectious Diseases Society of America and has been a member of the Institute of Medicine Committee on “Antivirals for Pandemic Influenza: Guidance on Developing and Distribution and Dispensing System.”  Dr. Pavia’s research interests include the epidemiology of influenza and other emerging infections; he has published more than 100 scientific articles and chapters.  He also has significant experience in the clinical development of antiviral compounds.  Dr. Pavia earned his M.D. degree from Brown University, served at the Centers for Disease Control as an Epidemic Intelligence Service Officer and a Preventive Medicine Resident, and is board certified in Internal Medicine and Infectious Diseases.

Robert Belshe, M.D.

Robert Belshe, MD is the Dianna and J. Joseph Adorjan Endowed Professor of Infectious Diseases and Immunology; Professor of Medicine, Pediatrics and Molecular Microbiology and Director for the Division of Infectious Diseases and Immunology at the St. Louis University School of Medicine.  He has published numerous key clinical articles on influenza vaccines and pathogenesis of influenza. Dr. Belshe is a diplomat on the American Board of Internal Medicine.

Kathryn Edwards, M.D.

Kathryn Edwards, MD holds the Sarah H. Sell Endowed Professorship in Pediatrics at Vanderbilt University School of Medicine.  In addition to having completed several peer review publications on infectious disease, influenza and parainfluenza in pediatric patients, Dr. Edwards is a current NIAID Advisory Council member and has been award multiple grants. She has published many pivotal articles on influenza vaccines and influenza pathogenesis in children. Dr. Edwards is board certified in pediatrics and infectious disease.

Allison McGeer, M.D., FRCPC

Allison McGeer MD, FRCPC is a Professor of Laboratory Medicine and Pathobiology at the University of Toronto, and Director of Infection Control and a Microbiologist at the Mount Sinai Hospital, Toronto. As a practicing clinician and researcher, Dr. McGeer has served on several councils and expert committees including the Council of Canadian Academies Expert Panel on Influenza and Respiratory Protection and the Canadian National Advisory Committee on Immunization. She has made key contributions to our understanding of the control of influenza outbreaks in institutions and of the epidemiology of influenza-associated hospitalization. Dr. McGeer trained in internal medicine and infectious diseases and is certified in Infectious Diseases by the Royal College of Physicians and Surgeons of Canada.

Richard Whitley, M.D.

Richard Whitley, MD is the Loeb Eminent Scholar Chair in Pediatrics; Professor of Pediatrics, Microbiology, Medicine and Neurosurgery; Co-Director, University of Alabama at Birmingham Center for Emerging Infections and Emergency Preparedness; Director, Division of Pediatric Infectious Diseases; Vice-Chairman, Department of Pediatrics; Senior Scientist, Department of Gene Therapy; Scientist, Cancer Research and Training Center;  Faculty, Gene Therapy Center University of Alabama at Birmingham. Dr. Whitley has served on several editorial and advisory boards and is currently the President of the Infectious Disease Society of America. Since 1980 Dr. Whitley has served as the Project Director for NIAID’s Collaborative Antiviral Study Group, a multi-center clinical trial network directed to conduct studies to evaluate novel antiviral therapies that target unmet medical needs.